150 related articles for article (PubMed ID: 31644616)
1. Leucine-rich glioma inactivated 3: a novel keratinocyte-derived melanogenic cytokine in vitiligo patients.
Farag AGA; Hammam MA; Al-Sharaky DR; El-Boghdady GM
An Bras Dermatol; 2019; 94(4):434-441. PubMed ID: 31644616
[TBL] [Abstract][Full Text] [Related]
2. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
3. Effect of narrow-band ultraviolet B on the serum of 25-hydroxyvitamin D in vitiligo patients.
Ibrahim H; El Taieb M; El Gamel Z; El Saied AR
J Cosmet Dermatol; 2018 Oct; 17(5):911-916. PubMed ID: 29524288
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
[No Abstract] [Full Text] [Related]
5. The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.
Ibrahim ZA; El-Ashmawy AA; El-Tatawy RA; Sallam FA
J Cosmet Dermatol; 2016 Jun; 15(2):108-16. PubMed ID: 26695436
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of tumor necrosis factor-α in vitiligo lesions after narrow-band UVB therapy: an immunohistochemical study.
Attwa E; Gamil H; Assaf M; Ghonemy S
Arch Dermatol Res; 2012 Dec; 304(10):823-30. PubMed ID: 22832941
[TBL] [Abstract][Full Text] [Related]
7. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
[TBL] [Abstract][Full Text] [Related]
8. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
[TBL] [Abstract][Full Text] [Related]
9. A comparative interventional study of narrowband ultraviolet B alone and narrowband ultraviolet B in combination with microneedling in patients with stable vitiligo.
Kaur A; Barman KD; Sahoo B; Choudhary P
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):357-363. PubMed ID: 36419200
[TBL] [Abstract][Full Text] [Related]
10. Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial.
Verhaeghe E; Lodewick E; van Geel N; Lambert J
Dermatology; 2011; 223(4):343-8. PubMed ID: 22269666
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy between localized 308-nm excimer light and targeted 311-nm narrowband ultraviolet B phototherapy in vitiligo: A randomized, single-blind comparison study.
Poolsuwan P; Churee C; Pattamadilok B
Photodermatol Photoimmunol Photomed; 2021 Mar; 37(2):123-130. PubMed ID: 33047405
[TBL] [Abstract][Full Text] [Related]
12. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of interrupted versus continuous narrowband ultraviolet B phototherapy in nonsegmental vitiligo treatment: A prospective randomized comparative study.
Anbar TS; Mohammed SS; Mohamed DM; Abdel-Rahman AT
Dermatol Ther; 2019 Nov; 32(6):e13117. PubMed ID: 31606939
[TBL] [Abstract][Full Text] [Related]
14. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
[TBL] [Abstract][Full Text] [Related]
15. Expression of Janus Kinase 1 in vitiligo & psoriasis before and after narrow band UVB: a case-control study.
Nada HR; El Sharkawy DA; Elmasry MF; Rashed LA; Mamdouh S
Arch Dermatol Res; 2018 Jan; 310(1):39-46. PubMed ID: 29127481
[TBL] [Abstract][Full Text] [Related]
16. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Spectrophotometric Evaluation of Skin Photoadaptation in Vitiligo Patients after a Short Cycle of NB-UVB Phototherapy.
Arisi M; Rossi MT; Fusano M; Gualini A; Tomasi C; Moggio E; Caravello S; Calzavara-Pinton P; Venturini M
Dermatology; 2019; 235(6):509-515. PubMed ID: 31586997
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Langerhans cells role in vitiligo and its relationship to NB-UVB.
Shoeib M; Farag AGA; Eltorgman M; Abdou AG
J Cosmet Dermatol; 2021 Nov; 20(11):3642-3648. PubMed ID: 33609002
[TBL] [Abstract][Full Text] [Related]
19. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
20. Combination of fractional carbon dioxide laser with narrow band ultraviolet B to induce repigmentation in stable vitiligo: A comparative study.
Doghaim NN; Gheida SF; El-Tatawy RA; Mohammed Ali DA
J Cosmet Dermatol; 2019 Feb; 18(1):142-149. PubMed ID: 29707867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]